Annual EBITDA
$851.39M$34.59M+4.23%
Summary
- Current Value
- As of today, ALGN annual EBITDA is $851.39M, up +4.23% on
- Historical Performance
- ALGN annual EBITDA is up +5.06% over the past 3 years, up +69.22% over the past 5 years
- All-Time High Comparison
- ALGN annual EBITDA is currently -23.43% below its historical high of $1.11B set on
- 3-Year Low Comparison
- ALGN annual EBITDA is +6.55% above its 3-year low of $799.06M reached on
- Sector Comparison
- ALGN annual EBITDA is higher than 92.46% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $851.39M | +4.2% | +5.1% | +69.2% | +654.8% | |
| Quarterly EBITDA | $243.69M | +15.1% | +19.8% | -17.6% | +620.2% | |
| TTM EBITDA | $979.65M | +21.7% | +28.6% | -10.7% | +812.7% | |
| Price | $155.17 | +16.8% | -27.9% | -77.3% | +591.8% | |
| PE Ratio | 22.55 | -12.4% | -50.6% | -69.3% | -28.6% | |
| Annual Revenue | $4.03B | +0.9% | +8.0% | +63.2% | +942.3% | |
| Annual EPS | $5.65 | +0.6% | +22.6% | -74.8% | +495.1% | |
| $616.22M | -8.3% | -5.8% | +59.2% | +524.9% | ||
| Annual Net Income | $410.35M | -2.6% | +13.5% | -76.9% | +452.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $851.39M | at high | |
| 5Y | $1.11B | -23.4% | |
| All | $1.11B | -23.4% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $799.06M | +6.5% | |
| 5Y | $503.14M | N/A | +69.2% |
| All | -$90.85M | +1037.1% |
EBITDA History
FAQ
- What is the current annual EBITDA of ALGN?
- As of today, ALGN annual EBITDA is $851.39M
- What is 1-year change in ALGN annual EBITDA?
- ALGN annual EBITDA is up +4.23% year-over-year
- What is 3-year change in ALGN annual EBITDA?
- ALGN annual EBITDA is up +5.06% over the past 3 years
- How far is ALGN annual EBITDA from its all-time high?
- ALGN annual EBITDA is currently -23.43% below its historical high of $1.11B set on December 31, 2021
- How does ALGN annual EBITDA rank versus sector peers?
- ALGN annual EBITDA is higher than 92.46% of companies in Healthcare sector
- When is ALGN next annual earnings release?
- The next annual earnings release for ALGN is on
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$243.69M$10.88M+4.67%
Summary
- Current Value
- As of today, ALGN quarterly EBITDA is $243.69M, up +4.67% on
- Historical Performance
- ALGN quarterly EBITDA is up +15.07% year-over-year, up +19.82% over the past 3 years
- All-Time High Comparison
- ALGN quarterly EBITDA is currently -19.12% below its historical high of $301.30M set on
- 3-Year Low Comparison
- ALGN quarterly EBITDA is +39.71% above its 3-year low of $174.43M reached on
- Sector Comparison
- ALGN quarterly EBITDA is higher than 91.43% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $243.69M | +4.7% | +15.1% | +19.8% | -17.6% | |
| Annual EBITDA | $851.39M | – | +4.2% | +5.1% | +69.2% | |
| TTM EBITDA | $979.65M | +3.4% | +21.7% | +28.6% | -10.7% | |
| Price | $155.17 | -2.4% | +16.8% | -27.9% | -77.3% | |
| PE Ratio | 22.55 | -18.2% | -12.4% | -50.6% | -69.3% | |
| Quarterly Revenue | $1.01B | -3.9% | +1.9% | +5.7% | -0.1% | |
| Quarterly EPS | $1.90 | +25.6% | +142.6% | +20.3% | -16.4% | |
| $204.27M | +6.0% | +30.9% | +22.8% | -21.8% | ||
| Quarterly Net Income | $135.04M | +24.7% | +137.9% | +11.2% | -25.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $261.59M | -6.8% | |
| 3Y | $261.59M | -6.8% | |
| 5Y | $295.73M | N/A | -17.6% |
| All | $301.30M | -19.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $211.78M | N/A | +15.1% |
| 3Y | $174.43M | +39.7% | |
| 5Y | $165.58M | +47.2% | |
| All | -$43.85M | +655.7% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of ALGN?
- As of today, ALGN quarterly EBITDA is $243.69M
- What is ALGN quarterly EBITDA most recent change?
- ALGN quarterly EBITDA was up +4.67% on September 30, 2026
- What is 1-year change in ALGN quarterly EBITDA?
- ALGN quarterly EBITDA is up +15.07% year-over-year
- How far is ALGN quarterly EBITDA from its all-time high?
- ALGN quarterly EBITDA is currently -19.12% below its historical high of $301.30M set on June 30, 2021
- How does ALGN quarterly EBITDA rank versus sector peers?
- ALGN quarterly EBITDA is higher than 91.43% of companies in Healthcare sector
- When is ALGN next earnings release?
- The next earnings release for ALGN is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$979.65M$31.91M+3.37%
Summary
- Current Value
- As of today, ALGN TTM EBITDA is $979.65M, up +3.37% on
- Historical Performance
- ALGN TTM EBITDA is up +21.69% year-over-year, up +28.63% over the past 3 years
- All-Time High Comparison
- ALGN TTM EBITDA is currently -11.84% below its historical high of $1.11B set on
- 3-Year Low Comparison
- ALGN TTM EBITDA is +28.63% above its 3-year low of $761.58M reached on an earlier date
- Sector Comparison
- ALGN TTM EBITDA is higher than 92.01% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $979.65M | +3.4% | +21.7% | +28.6% | -10.7% | |
| Annual EBITDA | $851.39M | – | +4.2% | +5.1% | +69.2% | |
| Quarterly EBITDA | $243.69M | +4.7% | +15.1% | +19.8% | -17.6% | |
| Price | $155.17 | -2.4% | +16.8% | -27.9% | -77.3% | |
| PE Ratio | 22.55 | -18.2% | -12.4% | -50.6% | -69.3% | |
| TTM Revenue | $4.16B | +0.5% | +4.4% | +9.2% | +10.7% | |
| TTM EPS | $6.88 | +19.4% | +33.4% | +46.0% | -25.9% | |
| $809.06M | +6.3% | +28.1% | +35.8% | -16.5% | ||
| TTM Net Income | $491.87M | +18.9% | +30.0% | +35.6% | -33.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $979.65M | at high | |
| 3Y | $979.65M | at high | |
| 5Y | $1.11B | -11.8% | |
| All | $1.11B | -11.8% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $805.04M | N/A | +21.7% |
| 3Y | $761.58M | N/A | +28.6% |
| 5Y | $741.73M | +32.1% | |
| All | -$106.47M | +1020.1% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of ALGN?
- As of today, ALGN TTM EBITDA is $979.65M
- What is ALGN TTM EBITDA most recent change?
- ALGN TTM EBITDA was up +3.37% on September 30, 2026
- What is 1-year change in ALGN TTM EBITDA?
- ALGN TTM EBITDA is up +21.69% year-over-year
- How far is ALGN TTM EBITDA from its all-time high?
- ALGN TTM EBITDA is currently -11.84% below its historical high of $1.11B set on December 31, 2021
- How does ALGN TTM EBITDA rank versus sector peers?
- ALGN TTM EBITDA is higher than 92.01% of companies in Healthcare sector
- When is ALGN next earnings release?
- The next earnings release for ALGN is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ALGN Official Website www.aligntech.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1097149/000109714926000006/0001097149-26-000006-index.htm
- ALGN Profile on Yahoo Finance finance.yahoo.com/quote/ALGN
- ALGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/algn
